Last updated on August 2018

A Study to Evaluate the Efficacy Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression


Brief description of study

The purpose of this study is to evaluate the efficacy of fixed dosed intranasal esketamine compared to intranasal placebo, as an add-on to an oral antidepressant in Japanese participants with treatment-resistant depression (TRD), in improving depressive symptoms.

Clinical Study Identifier: NCT02918318

Contact Investigators or Research Sites near you

Start Over

Use link at the bottom ...

Kuramitsu Hospital
Fukuoka, Japan
6.71miles
  Connect »

Use link at the bottom ...

Fukuoka University Hospital
Fukuoka, Japan
9.83miles
  Connect »